Junji Chiba

1.5k total citations
41 papers, 1.2k citations indexed

About

Junji Chiba is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Junji Chiba has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 12 papers in Hematology and 11 papers in Surgery. Recurrent topics in Junji Chiba's work include Rheumatoid Arthritis Research and Therapies (19 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Total Knee Arthroplasty Outcomes (7 papers). Junji Chiba is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (19 papers), Autoimmune and Inflammatory Disorders Research (12 papers) and Total Knee Arthroplasty Outcomes (7 papers). Junji Chiba collaborates with scholars based in Japan and United States. Junji Chiba's co-authors include Harry E. Rubash, Kazuhiko Inoue, Yuichi Iwaki, Kwang-Hwan Jung, W J Maloney, Thomas P. Schmalzried, Robert L. Smith, Kwang J. Kim, Toshihiko Satoh and Jun Kagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Joint Surgery and Clinical Orthopaedics and Related Research.

In The Last Decade

Junji Chiba

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Chiba Japan 14 656 387 201 116 100 41 1.2k
Shingo Hashimoto Japan 24 1.1k 1.7× 389 1.0× 278 1.4× 108 0.9× 126 1.3× 132 1.8k
Igor Borić Croatia 11 407 0.6× 726 1.9× 204 1.0× 215 1.9× 91 0.9× 44 1.2k
Damir Hudetz Croatia 13 453 0.7× 782 2.0× 231 1.1× 200 1.7× 89 0.9× 33 1.3k
V. Lascau-Coman Canada 13 357 0.5× 681 1.8× 167 0.8× 212 1.8× 83 0.8× 15 992
Zhuang Cui China 18 228 0.3× 345 0.9× 251 1.2× 119 1.0× 101 1.0× 40 841
Jennifer Woodell‐May United States 15 374 0.6× 403 1.0× 141 0.7× 86 0.7× 55 0.6× 25 981
Ming-liang Ji China 16 311 0.5× 351 0.9× 307 1.5× 159 1.4× 49 0.5× 47 1.0k
Yohei Kawakami Japan 22 569 0.9× 197 0.5× 342 1.7× 72 0.6× 118 1.2× 45 1.3k
Chian‐Her Lee Taiwan 18 544 0.8× 331 0.9× 114 0.6× 92 0.8× 51 0.5× 38 1.1k
M Mohtai Japan 12 326 0.5× 521 1.3× 220 1.1× 97 0.8× 90 0.9× 14 999

Countries citing papers authored by Junji Chiba

Since Specialization
Citations

This map shows the geographic impact of Junji Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Chiba more than expected).

Fields of papers citing papers by Junji Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Chiba. The network helps show where Junji Chiba may publish in the future.

Co-authorship network of co-authors of Junji Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Chiba. A scholar is included among the top collaborators of Junji Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Chiba. Junji Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kanbe, Katsuaki, et al.. (2016). Simultaneous Treatment with Subcutaneous Injection of Golimumab and Intra-articular Injection of Triamcinolone Acetonide (K-Method) in Patients with Rheumatoid Arthritis Undergoing Switching of Biologics: Retrospective Case–Control Study. SHILAP Revista de lepidopterología.
3.
Kanbe, Katsuaki, et al.. (2015). Biologic-free remission by orthopaedic surgery in non-responder to infliximab for rheumatoid arthritis. SpringerPlus. 4(1). 607–607. 1 indexed citations
5.
Kanbe, Katsuaki, et al.. (2014). Analysis of clinical factors related to the efficacy of shoulder arthroscopic synovectomy plus capsular release in patients with rheumatoid arthritis. European Journal of Orthopaedic Surgery & Traumatology. 25(3). 451–455. 12 indexed citations
6.
Ishijima, Muneaki, Toshitaka Nakamura, Katsuji Shimizu, et al.. (2014). Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial. Arthritis Research & Therapy. 16(1). R18–R18. 68 indexed citations
8.
Kanbe, Katsuaki, Junji Chiba, & Atsushi Nakamura. (2012). Immunohistological analysis of synovium treated with abatacept in rheumatoid arthritis. Rheumatology International. 33(7). 1883–1887. 14 indexed citations
9.
Kanbe, Katsuaki, Junji Chiba, & Atsushi Nakamura. (2012). Histological evaluation after arthroscopic reconstruction of the shoulder using a polytetrafluoroethylene patch for massive rotator cuff tears. European Journal of Orthopaedic Surgery & Traumatology. 23(S2). 183–187. 11 indexed citations
10.
Kanbe, Katsuaki, Junji Chiba, & Atsushi Nakamura. (2011). Decrease of CD68 and MMP-3 expression in synovium by treatment of adalimumab for rheumatoid arthritis. International Journal of Rheumatic Diseases. 14(3). 261–266. 20 indexed citations
11.
Kanbe, Katsuaki, et al.. (2010). Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab. International Journal of Rheumatic Diseases. 14(1). 31–36. 20 indexed citations
12.
Suzuki, Yutaka, Kazuhiko Inoue, Junji Chiba, Yasuo Inoue, & Katsuaki Kanbe. (2009). Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis. International Journal of Rheumatic Diseases. 12(1). 7–13. 6 indexed citations
13.
Nanke, Yuki, Manabu Kawamoto, Toru Yago, et al.. (2009). Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Modern Rheumatology. 19(4). 379–383. 9 indexed citations
14.
Murata, Minako, Hiroshi Nakamura, Junji Chiba, et al.. (2008). Hypoxia upregulates the expression of angiopoietin‐like‐4 in human articular chondrocytes: Role of angiopoietin‐like‐4 in the expression of matrix metalloproteinases and cartilage degradation. Journal of Orthopaedic Research®. 27(1). 50–57. 51 indexed citations
15.
Murata, Minako, Kazuo Yudoh, Hiroshi Nakamura, et al.. (2006). Distinct signaling pathways are involved in hypoxia- and IL-1-induced VEGF expression in human articular chondrocytes. Journal of Orthopaedic Research®. 24(7). 1544–1554. 38 indexed citations
16.
Chiba, Junji, William J. Maloney, Kazuhiko Inoue, & Harry E. Rubash. (2001). Biochemical analyses of human macrophages activated by polyethylene particles retrieved from interface membranes after failed total hip arthroplasty. The Journal of Arthroplasty. 16(8). 101–105. 11 indexed citations
17.
Ozawa, Yuki, Junji Chiba, & S. Sakamoto. (2001). HLA class II alleles and salivary numbers of mutans streptococci and lactobacilli among young adults in Japan. Oral Microbiology and Immunology. 16(6). 353–357. 19 indexed citations
18.
Satoh, Toshihiko, et al.. (2000). Interleukin–6 and interleukin–8 levels in serum and synovial fluid of patients with osteoarthritis. PubMed. 6(2). 71–79. 218 indexed citations
20.
Chiba, Junji, Yoshihiro Asanuma, Shuji Matsubara, et al.. (1985). A case of postoperative liver failure successfully treated with plasma exchange.. The Tohoku Journal of Experimental Medicine. 146(3). 375–376. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026